CNSX:VP - Vodis Pharmaceuticals Stock Price, News, & Analysis

$0.06
0.00 (0.00 %)
(As of 07/19/2019 04:00 PM ET)
Today's Range
$0.06
Now: $0.0650
$0.07
50-Day Range
$0.06
MA: $0.07
$0.0850
52-Week Range
$0.16
Now: $0.0650
$0.62
Volume28,000 shs
Average Volume1,714 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Vodis Pharmaceuticals Inc. operates as an application stage company for producing medical marijuana. It operates in Canada and the United States. The company is based in Delta, Canada.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone778-990-8985

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive VP News and Ratings via Email

Sign-up to receive the latest news and ratings for VP and its competitors with MarketBeat's FREE daily newsletter.

Vodis Pharmaceuticals (CNSX:VP) Frequently Asked Questions

What is Vodis Pharmaceuticals' stock symbol?

Vodis Pharmaceuticals trades on the CNSX under the ticker symbol "VP."

Has Vodis Pharmaceuticals been receiving favorable news coverage?

Media headlines about VP stock have trended very negative recently, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Vodis Pharmaceuticals earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the immediate future. View News Stories for Vodis Pharmaceuticals.

Who are some of Vodis Pharmaceuticals' key competitors?

What other stocks do shareholders of Vodis Pharmaceuticals own?

Who are Vodis Pharmaceuticals' key executives?

Vodis Pharmaceuticals' management team includes the folowing people:
  • Mr. Brian R. Gusko, Advisor (Age 52)
  • Mr. Mark Lotz B.B.A., C.A., CPA, Interim CEO, CFO & Director

How do I buy shares of Vodis Pharmaceuticals?

Shares of VP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vodis Pharmaceuticals' stock price today?

One share of VP stock can currently be purchased for approximately $0.0650.

What is Vodis Pharmaceuticals' official website?

The official website for Vodis Pharmaceuticals is http://vodis.ca/.

How can I contact Vodis Pharmaceuticals?

The company can be reached via phone at 778-990-8985.


MarketBeat Community Rating for Vodis Pharmaceuticals (CNSX VP)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  21 (Vote Outperform)
Underperform Votes:  14 (Vote Underperform)
Total Votes:  35
MarketBeat's community ratings are surveys of what our community members think about Vodis Pharmaceuticals and other stocks. Vote "Outperform" if you believe VP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/20/2019 by MarketBeat.com Staff

Featured Article: Capital Gains

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel